Cite
Early diaphragm pacing in patients with amyotrophic lateral sclerosis (RespiStimALS): a randomised controlled triple-blind trial.
MLA
Gonzalez-Bermejo, Jésus, et al. “Early Diaphragm Pacing in Patients with Amyotrophic Lateral Sclerosis (RespiStimALS): A Randomised Controlled Triple-Blind Trial.” Lancet Neurology, vol. 15, no. 12, Nov. 2016, pp. 1217–27. EBSCOhost, https://doi.org/10.1016/S1474-4422(16)30233-2.
APA
Gonzalez-Bermejo, J., Morélot-Panzini, C., Tanguy, M.-L., Meininger, V., Pradat, P.-F., Lenglet, T., Bruneteau, G., Forestier, N. L., Couratier, P., Guy, N., Desnuelle, C., Prigent, H., Perrin, C., Attali, V., Fargeot, C., Nierat, M.-C., Royer, C., Ménégaux, F., Salachas, F., & Similowski, T. (2016). Early diaphragm pacing in patients with amyotrophic lateral sclerosis (RespiStimALS): a randomised controlled triple-blind trial. Lancet Neurology, 15(12), 1217–1227. https://doi.org/10.1016/S1474-4422(16)30233-2
Chicago
Gonzalez-Bermejo, Jésus, Capucine Morélot-Panzini, Marie-Laure Tanguy, Vincent Meininger, Pierre-François Pradat, Timothée Lenglet, Gaëlle Bruneteau, et al. 2016. “Early Diaphragm Pacing in Patients with Amyotrophic Lateral Sclerosis (RespiStimALS): A Randomised Controlled Triple-Blind Trial.” Lancet Neurology 15 (12): 1217–27. doi:10.1016/S1474-4422(16)30233-2.